authors
- Alderman, M
- Arakawa, K
- Beilin, L
- Chalmers, J
- Cohn, J
- Collins, R
- Fenichel, RR
- Frohlich, ED
- Hamet, P
- Hansson, L
- Hennekens, C
- Kuschnir, E
- Liu, LS
- MacMahon, S
- Mancia, G
- Martin, I
- Menard, J
- Sleight, P
- Whitworth, J
- Yusuf, Salim
- Zanchetti, A
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 1997
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1116 Medical Physiology (FoR)
- Calcium Channel Blockers (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Case-Control Studies (MeSH)
- Coronary Disease (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Neoplasms (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Risk (MeSH)
published in
- Journal of Hypertension Journal